广州卡洛莱化妆品有限公司
20人以下
公司优势
20,861+ 岗位更新等你来订阅
一键订阅最新的岗位，每周送达
🎉恭喜你，订阅成功
继续订阅您可以在邮箱中随时取消订阅
谷城艺美家装饰
CStone Pharmaceuticals is an innovative, research-driven biopharmaceutical enterprise dedicated to pioneering the development of cutting-edge therapeutic medications. Situated in both Shanghai and Suzhou, the company boasts a leadership team comprised of experienced executives from leading multinational pharmaceutical corporations. In July 2016, CStone disclosed the successful conclusion of its Series A funding round, securing a total investment of $150 million (approximately 975 million RMB). This round was co-invested by three prominent industry investors: Oriza Seed Venture Capital (Oriza Seed), Boyu Capital, and WuXi Healthcare Ventures (WXHV).
With an unwavering commitment to addressing the critical healthcare needs of Chinese patients, CStone's extensive pipeline encompasses five therapeutic areas: oncology, cardiovascular diseases, rheumatoid arthritis, hematology, and autoimmune disorders. The company's strategic focus on immuno-oncology serves as its cornerstone, aiming to propel Chinese research onto the global stage through its world-class research and development capabilities, an innovative drug portfolio, and an open innovation approach.
CStone Pharmaceuticals is a pioneering, research-focused biopharmaceutical company headquartered in Shanghai and Suzhou, China. Its executive team comprises seasoned professionals from top-tier multinational pharmaceutical firms. In July 2016, the company successfully concluded its Series A funding round, attracting a total investment of $150 million (equivalent to approximately 975 million RMB). This round was jointly supported by three distinguished industry investors: Oriza Seed Venture Capital (Oriza Seed), Boyu Capital, and WuXi Healthcare Ventures (WXHV).
Driven by a mission to meet the pressing medical needs of Chinese patients, CStone's comprehensive product pipeline spans across five therapeutic sectors: oncology, cardiovascular diseases, rheumatoid arthritis, hematology, and autoimmune diseases. With immuno-oncology at the heart of its strategic focus, the company aspires to position Chinese research on the global stage, leveraging its world-class research and development expertise, innovative drug portfolio, and an open innovation philosophy.
山东电力设备厂是山东电力集团公司旗下的大型国有企业，其电站风机产品及备品配件等远销至印度、朝鲜、蒙古、孟加拉等国，年销售额超3亿元。该企业获国家质量学会、国家商品学会授予的全国同行业“优级品牌”称号，“辰明牌”电力变压器连续五年被评为“山东名牌”，并荣膺山东省“省级文明单位”称号及“山东省富民兴鲁劳动奖状”。企业具备完善的质量保障体系，于2003年通过国家级ISO9001质量、ISO14001环境管理体系双认证，同年还荣获“全国重合同守信用企业”称号。
拓松（绍兴）生物医药科技有限公司专注于利用先进的微通道连续流技术解决医药生产中的本质安全问题，推动微通道连续流技术在医药和生命大健康领域的应用与发展，为国内外医药企业提供微通道技术服务，并通过连续流技术生产高附加值原料药及化工产品，是一家高科技研发型企业。
公司位于绍兴市滨海新区生命健康科技产业园4号楼北侧4楼，面积1000平米，一期投资3000万元。公司掌握微通道反应器研发药物绿色、安全、可连续生产的环保生产工艺核心技术，拥有微通道连续流反应相关发明专利7项、实用新型专利6项、软件著作权4项，具备强大的科研开发能力。2022年，公司创始人获得首届中国绍兴“万亩千亿”全球创业大赛高端生物医药系列赛一等奖。
拓松公司服务于国内外传统大、中型医药生产企业、化工产品生产企业以及医药、化妆品、化工行业的研发型企业。公司业务位于医药化工产业链前端，所提供的服务与产品能有效帮助企业解决安全、环保、增效降耗等问题。目前，国内微通道连续流反应技术正快速发展，众多企业纷纷布局该领域，而拓松公司较早开展微通道连续流业务，技术水平在国内处于领先地位，未来发展潜力巨大。
公司成立于2003年3月，专注于收银系统的软硬件系统集成。经过多年运营与发展，已成为行业内知名的POS收银设备专业集成商。自成立以来的十余年间，凭借在应用领域深厚的技术实力，公司为客户提供商业信息管理系统、办公自动化系统、网络设计安装、商业管理咨询、技术支持、技术培训以及系统维护等全方位解决方案。